Search

everythinglearnresearchcommunity

for

Search:↓

Obese women with PCOS are more likely to have fatty liver disease.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The normal human prostate does not significantly affect blood DHT levels.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Optimizing production conditions can improve hyaluronic acid's effectiveness and cost in cosmetics and therapy.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

PCOS is a major cause of infertility and requires personalized treatment.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.